Search

Four leading research groups are combining forces to find genetic links to Alzheimer’s disease.

Unusually, innovation is on the agenda at the meeting Feb. 4 of European leaders in Brussels. On the eve of this summit, a group of innovation leaders calls for a sweeping overhaul of the system.

Former Academic Enterprise Award (ACES) winner Novacem, a spin-out specialised in carbon negative cement, has secured a follow-on investment from the London Technology Fund.

University College London cancer vaccines spin-out BioVex has been bought by US biotech company Amgen in deal worth up to $1 billion.

The Swiss Federal Institute of Technology in Lausanne has just opened the doors to a new national robotics research centre that aims to usher in a new era of robots, designed to do useful things in ordinary circumstances.